IIM
FDMT icon

INTECH Investment Management’s 4D Molecular Therapeutics FDMT Stock Holding History

INTECH Investment Management’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100K Sell
10,746
-6,882
-39% -$59.9K ﹤0.01% 1893
2025
Q4 		$132K Sell
17,628
-1,023
-5% -$10.4K ﹤0.01% 2099
2025
Q3 		$162K Sell
18,651
-1,446
-7% -$8.64K ﹤0.01% 2139
2025
Q2 		$74.6K Sell
20,097
-19,178
-49% -$67.4K ﹤0.01% 2358
2025
Q1 		$127K Buy
39,275
+17,441
+80% +$82.2K ﹤0.01% 2249
2024
Q4 		$122K Sell
21,834
-2,927
-12% -$23K ﹤0.01% 2165
2024
Q3 		$268K Buy
+24,761
New +$411K ﹤0.01% 1578

Other funds holding FDMT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return